ZBTB17 and atherosclerosis: Therefore, we speculate that NKRF and ZBTB17 may regulate the progression of Alzheimer's disease (AD) and atherosclerosis (AS) by modulating NF‐κB and its related signaling pathways in microglia and macrophages.